AI-DRIVEN PRECISION MEDICINE: REVOLUTIONIZING PERSONALIZED TREATMENT PLANS
Keywords:
AI-Driven Precision Medicine, Personalized Treatment Plans, Predictive Modeling, Drug DiscoveryAbstract
Precision medicine has been described as a revolution currently occurring in the field of healthcare. The advance of Integrated Artificial Intelligence (IAI) in precision medicine is providing a new perspective of the healthcare sector and creating high-quality efficient, individualized treatment plans. In this article, the application of artificial intelligence (AI) in precision medicine has been examined with a focus on how it improves the identification of disease risks, treatment management, and patient outcomes based on the analysis of genetics and clinical and environmental information. Applications include AI algorithms for machine learning and deep learning to enhance biomarkers’ detection, the production of accurate models, and the discovery of suitable treatments for individuals. In the area of precision medicine, AI is not limited to diagnostic and treatment recommendations, though; it is also employed in the identification of drugs for treatment, management of clinical trials, and tracking of patients’ progress. With the help of AI in healthcare, patients can receive customized and innovative care that minimizes the side effects of therapies or treatments, has higher chances of effectiveness, and enhances patient's health overall. Of course, the use of AI in precision medicine has some limitations, such as issues with data privacy and protection, the use of large and diverse datasets (especially in the case of genetic variations), and the likelihood of biases in the use of AI algorithms. Solving these issues is difficult and can only be done through teamwork where clinicians, data scientists, and policymakers can ensure that precision medicine with AI is both good and universally available. Still precision medicine is a promising interdisciplinary approach to treating patients based on their particular features, and this article gives an overview of different technologies, as well as methods and applications of precision medicine in the context of artificial intelligence. It further highlights the advantages and uncertainties concerning this fairly new and progressing area and presents suggestions as to the conception of AI in the healthcare direction
References
Lee, D. (2023). AI-Driven Drug Discovery and Development for Precision Medicine. African Journal of Artificial Intelligence and Sustainable Development, 3(1), 1-11.
Johnson, K. B., Wei, W. Q., Weeraratne, D., Frisse, M. E., Misulis, K., Rhee, K., ... & Snowdon, J. L. (2021). Precision medicine, AI, and the future of personalized health care. Clinical and translational science, 14(1), 86-93.
Mesko, B. (2017). The role of artificial intelligence in precision medicine. Expert Review of Precision Medicine and Drug Development, 2(5), 239-241.
Saxena, S., Jena, B., Gupta, N., Das, S., Sarmah, D., Bhattacharya, P., & Suri, J. S. (2022). Role of artificial intelligence in radiogenomics for cancers in the era of precision medicine. Cancers, 14(12), 2860.
Lorkowski, J., Kolaszyńska, O., & Pokorski, M. (2021). Artificial intelligence and precision medicine: A perspective. In Integrative Clinical Research (pp. 1-11). Cham: Springer International Publishing.
Berdigaliyev, N., & Aljofan, M. (2020). An overview of drug discovery and development. Future medicinal chemistry, 12(10), 939-947.
Mohs, R. C., & Greig, N. H. (2017). Drug discovery and development: Role of basic biological research. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 3(4), 651-657.
Sinha, S., & Vohora, D. (2018). Drug discovery and development: An overview. Pharmaceutical medicine and translational clinical research, 19-32.
Martínez-García, M., & Hernández-Lemus, E. (2022). Data integration challenges for machine learning in precision medicine. Frontiers in medicine, 8, 784455.
Boniolo, F., Dorigatti, E., Ohnmacht, A. J., Saur, D., Schubert, B., & Menden, M. P. (2021). Artificial intelligence in early drug discovery enables precision medicine. Expert Opinion on Drug Discovery, 16(9), 991-1007.
He, X., Liu, X., Zuo, F., Shi, H., & Jing, J. (2023, January). Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. In Seminars in Cancer Biology (Vol. 88, pp. 187-200). Academic Press.
Dhiman, G., Juneja, S., Viriyasitavat, W., Mohafez, H., Hadizadeh, M., Islam, M. A., ... & Gulati, K. (2022). A novel machine-learning-based hybrid CNN model for tumor identification in medical image processing. Sustainability, 14(3), 1447.
Recurrent Neural Network, botpenguin, online. https://botpenguin.com/glossary/recurrent-neural-network
Raparthi, M. (2021). AI-Driven Decision Support Systems for Precision Medicine: Examining the Development and Implementation of AI-Driven Decision Support Systems in Precision Medicine. Journal of Artificial Intelligence Research, 1(1), 11-20.
Pitts, N. B., & Richards, D. (2009). Personalized treatment planning. Detection, Assessment, Diagnosis and Monitoring of Caries, 21, 128-143.
Kasula, B. Y. (2021). AI-Driven Innovations in Healthcare: Improving Diagnostics and Patient Care. International Journal of Machine Learning and Artificial Intelligence, 2(2), 1-8.
Gifari, M. W., Samodro, P., & Kurniawan, D. W. (2021). Artificial intelligence toward personalized medicine. Pharmaceut. Sci. Res, 8(2), 1.
